This may also be one of the reasons why STAT3 has dual functions in cancer promotion and inhibition.[35, 36, 37] Thus, it is not difficult to predict the successful clinical application of small‐molecule inhibitors targeting STAT3 dimerization. The gene discussed is STAT3; the disease is cancer.